Concepts (116)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Cytological Techniques | 2 | 2011 | 17 | 0.720 |
Why?
|
| Thymus Gland | 1 | 2011 | 105 | 0.350 |
Why?
|
| Papillomaviridae | 1 | 2011 | 189 | 0.320 |
Why?
|
| Sarcoma, Kaposi | 2 | 2008 | 137 | 0.320 |
Why?
|
| Dendritic Cell Sarcoma, Follicular | 1 | 2008 | 2 | 0.310 |
Why?
|
| Neurofibroma | 1 | 2008 | 6 | 0.290 |
Why?
|
| Thyroid Neoplasms | 1 | 2011 | 255 | 0.280 |
Why?
|
| Neurilemmoma | 1 | 2008 | 48 | 0.280 |
Why?
|
| Orbital Neoplasms | 1 | 2008 | 66 | 0.270 |
Why?
|
| Orbit | 1 | 2008 | 107 | 0.270 |
Why?
|
| Lung Transplantation | 2 | 2008 | 335 | 0.270 |
Why?
|
| Papillomavirus Infections | 1 | 2011 | 398 | 0.250 |
Why?
|
| Schizophrenia | 2 | 2012 | 332 | 0.250 |
Why?
|
| Workload | 1 | 2024 | 151 | 0.210 |
Why?
|
| Rhabdoid Tumor | 1 | 2023 | 56 | 0.210 |
Why?
|
| Schizophrenic Psychology | 1 | 2004 | 85 | 0.210 |
Why?
|
| Cell Differentiation | 1 | 2011 | 2025 | 0.210 |
Why?
|
| Burnout, Professional | 1 | 2024 | 130 | 0.200 |
Why?
|
| Medical Informatics | 1 | 2024 | 113 | 0.190 |
Why?
|
| Anesthesiology | 1 | 2024 | 103 | 0.190 |
Why?
|
| Mammary Analogue Secretory Carcinoma | 1 | 2021 | 8 | 0.180 |
Why?
|
| Self Report | 1 | 2024 | 552 | 0.180 |
Why?
|
| Salivary Gland Neoplasms | 1 | 2021 | 67 | 0.180 |
Why?
|
| Mental Health Services | 1 | 2004 | 280 | 0.170 |
Why?
|
| Lung Neoplasms | 2 | 2008 | 1788 | 0.170 |
Why?
|
| Cognition Disorders | 1 | 2004 | 579 | 0.160 |
Why?
|
| Kidney Neoplasms | 1 | 2023 | 463 | 0.160 |
Why?
|
| Carcinoma | 1 | 2021 | 322 | 0.150 |
Why?
|
| Primary Health Care | 1 | 2024 | 794 | 0.140 |
Why?
|
| Immunohistochemistry | 3 | 2011 | 1761 | 0.140 |
Why?
|
| Tissue Donors | 2 | 2010 | 525 | 0.120 |
Why?
|
| Antipsychotic Agents | 2 | 2012 | 388 | 0.110 |
Why?
|
| Brain Neoplasms | 1 | 2023 | 1409 | 0.110 |
Why?
|
| Diagnosis, Differential | 2 | 2008 | 1977 | 0.100 |
Why?
|
| Parahippocampal Gyrus | 1 | 2012 | 2 | 0.100 |
Why?
|
| Middle Aged | 7 | 2012 | 29409 | 0.090 |
Why?
|
| Fibrosarcoma | 1 | 2011 | 27 | 0.090 |
Why?
|
| Cell Aggregation | 1 | 2011 | 25 | 0.090 |
Why?
|
| Herpesvirus 8, Human | 2 | 2008 | 52 | 0.090 |
Why?
|
| Fibroma | 1 | 2011 | 31 | 0.090 |
Why?
|
| Foot | 1 | 2011 | 65 | 0.090 |
Why?
|
| Cervix Uteri | 1 | 2011 | 64 | 0.090 |
Why?
|
| Fatal Outcome | 2 | 2008 | 376 | 0.080 |
Why?
|
| HSP40 Heat-Shock Proteins | 1 | 2009 | 24 | 0.080 |
Why?
|
| Cord Blood Stem Cell Transplantation | 1 | 2010 | 46 | 0.080 |
Why?
|
| Humans | 15 | 2024 | 133937 | 0.080 |
Why?
|
| Neoplasm Transplantation | 1 | 2010 | 399 | 0.080 |
Why?
|
| Heat-Shock Proteins | 1 | 2009 | 202 | 0.070 |
Why?
|
| Transplants | 1 | 2008 | 37 | 0.070 |
Why?
|
| Uterine Cervical Neoplasms | 1 | 2011 | 267 | 0.070 |
Why?
|
| Biomarkers, Tumor | 2 | 2021 | 1720 | 0.070 |
Why?
|
| Chromatin | 1 | 2011 | 609 | 0.070 |
Why?
|
| Ophthalmologic Surgical Procedures | 1 | 2008 | 90 | 0.070 |
Why?
|
| Biopsy, Needle | 1 | 2008 | 238 | 0.070 |
Why?
|
| Radiopharmaceuticals | 1 | 2008 | 171 | 0.070 |
Why?
|
| Fluorodeoxyglucose F18 | 1 | 2008 | 136 | 0.070 |
Why?
|
| Early Detection of Cancer | 1 | 2011 | 413 | 0.070 |
Why?
|
| Pulmonary Fibrosis | 1 | 2008 | 110 | 0.070 |
Why?
|
| Biopsy, Fine-Needle | 2 | 2021 | 123 | 0.070 |
Why?
|
| Hippocampus | 1 | 2012 | 861 | 0.060 |
Why?
|
| Positron-Emission Tomography | 1 | 2008 | 310 | 0.060 |
Why?
|
| Cystic Fibrosis | 1 | 2008 | 264 | 0.060 |
Why?
|
| Leukemia, Myeloid, Acute | 1 | 2010 | 569 | 0.050 |
Why?
|
| Headache | 1 | 2024 | 111 | 0.050 |
Why?
|
| Biopsy | 1 | 2008 | 1304 | 0.050 |
Why?
|
| Workflow | 1 | 2024 | 133 | 0.050 |
Why?
|
| Psychology | 1 | 2004 | 61 | 0.050 |
Why?
|
| Autopsy | 1 | 2023 | 119 | 0.050 |
Why?
|
| Female | 7 | 2012 | 71682 | 0.050 |
Why?
|
| Inflammation | 1 | 2011 | 1599 | 0.050 |
Why?
|
| Ambulatory Care Facilities | 1 | 2024 | 239 | 0.050 |
Why?
|
| Prognosis | 2 | 2009 | 5081 | 0.050 |
Why?
|
| Melanoma | 1 | 2009 | 975 | 0.050 |
Why?
|
| Skin Neoplasms | 1 | 2009 | 907 | 0.050 |
Why?
|
| Membrane Proteins | 1 | 2009 | 1606 | 0.050 |
Why?
|
| Salivary Glands | 1 | 2021 | 35 | 0.050 |
Why?
|
| Fellowships and Scholarships | 1 | 2024 | 314 | 0.040 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2012 | 3850 | 0.040 |
Why?
|
| Lung | 1 | 2008 | 1557 | 0.040 |
Why?
|
| Neuropsychological Tests | 1 | 2004 | 983 | 0.040 |
Why?
|
| Tomography, X-Ray Computed | 1 | 2008 | 2196 | 0.040 |
Why?
|
| Health Personnel | 1 | 2024 | 540 | 0.040 |
Why?
|
| Adult | 5 | 2012 | 31949 | 0.040 |
Why?
|
| Oncogene Proteins, Fusion | 1 | 2021 | 233 | 0.040 |
Why?
|
| Aged, 80 and over | 1 | 2011 | 7212 | 0.040 |
Why?
|
| Education, Medical, Graduate | 1 | 2024 | 560 | 0.040 |
Why?
|
| Follow-Up Studies | 1 | 2008 | 5511 | 0.040 |
Why?
|
| Risk Assessment | 1 | 2008 | 3699 | 0.040 |
Why?
|
| United States | 2 | 2024 | 11687 | 0.040 |
Why?
|
| Electronic Health Records | 1 | 2024 | 790 | 0.030 |
Why?
|
| Child | 2 | 2024 | 25739 | 0.030 |
Why?
|
| Young Adult | 1 | 2011 | 9889 | 0.030 |
Why?
|
| Postoperative Complications | 1 | 2008 | 3227 | 0.030 |
Why?
|
| Aged | 2 | 2011 | 21746 | 0.030 |
Why?
|
| Cross-Sectional Studies | 1 | 2024 | 3739 | 0.030 |
Why?
|
| Surveys and Questionnaires | 1 | 2024 | 3989 | 0.030 |
Why?
|
| Infant | 2 | 2023 | 13161 | 0.020 |
Why?
|
| Retrospective Studies | 1 | 2011 | 17488 | 0.020 |
Why?
|
| Adolescent | 1 | 2011 | 20534 | 0.020 |
Why?
|
| Functional Neuroimaging | 1 | 2012 | 35 | 0.020 |
Why?
|
| Treatment Outcome | 1 | 2008 | 13013 | 0.020 |
Why?
|
| Male | 4 | 2012 | 65902 | 0.020 |
Why?
|
| Immunophenotyping | 1 | 2010 | 342 | 0.020 |
Why?
|
| Breast Neoplasms | 1 | 2021 | 2763 | 0.020 |
Why?
|
| Doxorubicin | 1 | 2008 | 300 | 0.020 |
Why?
|
| Bone Marrow Transplantation | 1 | 2010 | 621 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2008 | 693 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2009 | 1139 | 0.020 |
Why?
|
| Sirolimus | 1 | 2008 | 253 | 0.020 |
Why?
|
| Viral Load | 1 | 2008 | 412 | 0.020 |
Why?
|
| Recurrence | 1 | 2010 | 1471 | 0.020 |
Why?
|
| Radiography | 1 | 2008 | 826 | 0.020 |
Why?
|
| Neoplasm Staging | 1 | 2009 | 1386 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2012 | 3639 | 0.010 |
Why?
|
| Immunosuppressive Agents | 1 | 2008 | 693 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2010 | 14800 | 0.010 |
Why?
|